4-Hydroxychalcone Inhibits Human Coronavirus HCoV-OC43 by Targeting EGFR/AKT/ERK1/2 Signaling Pathway

Human coronaviruses are a group of viruses that continue to threaten human health. In this study, we investigated the Antiviral activity of 4-hydroxychalcone (4HCH), a chalcone derivative, against human coronavirus HCoV-OC43. We found that 4HCH significantly inhibited the cytopathic effect, reduced viral protein and RNA levels in infected cells, and increased the survival rate of HCoV-OC43-infected suckling mice. Mechanistically, 4HCH targets the early stages of viral Infection by binding to the epidermal growth factor receptor (EGFR) and inhibiting the EGFR/Akt/ERK1/2 signaling pathway, thereby suppressing viral replication. Additionally, 4HCH significantly reduced the production of pro-inflammatory cytokines and chemokines in both HCoV-OC43-infected RD cells and a suckling mouse model. Our findings demonstrate that 4HCH exhibits potent Antiviral activity both in vitro and in vivo, suggesting its potential as a therapeutic agent against human coronaviruses. This study highlights EGFR as a promising host target for Antiviral drug development and positions 4HCH as a candidate for further investigation in the treatment of coronavirus infections.

4-hydroxychalcone; EGFR; EGFR/AKT/ERK1/2 signaling pathway; antiviral activity; flavonoids; human coronavirus.